Variables Influencing Outcome of Helicobacter pylori Eradication Therapy in South China

Helicobacter

Volumn 14, Issue 5, 2009, Pages 443-448

  Cai, Wenzhi ^a,b   Zhou, Liping ^b   Ren, Wei ^b   Deng, Ling ^b   Yu, Min ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Eradication; Helicobacter pylori; Infection; Influencing fact

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; CHINA; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EDUCATIONAL STATUS; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA; NONHUMAN; OCCUPATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; TASTE DISORDER; TREATMENT OUTCOME; UREA BREATH TEST; VOMITING;

HELICOBACTER PYLORI;

EID: 70349151377     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00718.x     Document Type: Article

References (24)

1. Hu F. A number of consensus views about the Helicobacter pylori infection, clinical disease and treatment: the epidemiology of Helicobacter pylori infection. China Medical News 2006 21 : 20.
2. Hu F. Helicobacter pylori infection treatment guide. Beijing: People's Medical Publishing House 2006 1 : 10 9.
3. Moss SF, Malfertheiner P. Helicobacter and gastric malignancies. Helicobacter 2007 12 : 23 30.
4. Rhead JL, Letley DP, Mohammadi M, et al. A new Helicobacter pylori vocuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007 133 : 26 36.
5. Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. Am J Gastroenterol 2005 100 : 2083 2099.
6. Thong-Ngam D, Mahachai V, Kullavanijaya P. Incidence of Helicobacter pylori recurrent infection and associated factors in Thailand. J Med Assoc Thai 2007 90 : 1406 1410.
7. Ahmad MM, Ahmed DS, Rowshon AH, et al. Long-term re-infection rate after Helicobacter pylori eradication in Bangladeshi adults. Digestion 2007 75 : 173 176.
8. Magelhaes Queiroz DM, Luzza F. Epidemiology of Helicobacter pylori infection. Helicobacter 2006 11 : 1 5.
9. Hu F. Epidemiology on Helicobacter Pylori infection. Chin J Med 2007 42 : 17 8.
10. Zhao X, Zhao H, Zhang A, et al. Endoscopy room medical personnel and the risk of occupational exposure to interventions. Chinese Journal of Disinfection 2008 25 : 656 657.
11. Malfertheiner P, Megraud F, Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007 56 : 772 781. (Pubitemid 46854190)
12. Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998 93 : 2330 2338.
13. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002 16 : 167 180.
14. Egan BJ, Marzio L, O'Connor H, et al. Treatment of Helicobacter Pylori infection. Helicobacter 2008 13 : 35 40.
15. Chen SY, Liu T, Fan X. Epidemiology on Helicobacter pylori infection and risk factors in Shanghai. Chin Med J 2005 85 : 802 806.
16. Graham DY, Lew GM, Malaty H M, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992 102 : 493 498.
17. Gisbert JP, Pajares R, Pajares JM. Evolution of Helicobacter pylori therapy from a meta-analytical perspective. Helicobacte 2007 12 : 50 2.
18. Yu WH, Zhou DQ, Zhou XM, et al. The effect of type 2 diabetes mellitus on eradication rate of Helicobacter pylori. Chin Gen Prac 2004 7 : 1472 1474.
19. 13C urea breath analyses for Helicobacter pylori. Aliment Pharmacol Ther 2001 19 : 389 394.
20. de Boer WA, Thys JC, Borody TJ, et al. Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. Eur J Gastroenterol Hepato 1996 8 : 641 643.
21. Nobue U, Kazumasa M, Masafumi K, et al. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure. Helicobacter 2009 14 : 91 9.
22. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004 53 : 1374 1384.
23. Cheng H, Hu FL, Xie Y, et al. Prevalence of Helicobacter pylori resistance to antibiotics and its influence on the treatment outcome in China: a multicenter clinical study [ J ]. Chin J Gastroenterol 2007 12 : 525 530.
24. Tong JL, Ran ZH, Shen J, et al. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007 25 : 155 168.